Alembic Pharmaceuticals informs about updates

09 Mar 2024 Evaluate

Alembic Pharmaceuticals has informed the exchange that the Company has successfully completed the United States Food and Drug Administration (USFDA) inspection at its Oncology (injectable and Oral Solid) Formulation Facility at Panelav. The inspection was conducted from February 28, 2024 to March 8, 2024. The USFDA issued a Form 483 with four procedural observation.

The above information is a part of company’s filings submitted to BSE.


Alembic Pharma Share Price

1039.90 1.70 (0.16%)
22-Nov-2024 11:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1771.65
Dr. Reddys Lab 1205.10
Cipla 1479.65
Lupin 2053.05
Zydus Lifesciences 942.80
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.